Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,884
datasets available to search
ShareScore release 0.9.0
Dataset results
2,884 results for “cancer resistance”
Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA)
ClinicalTrials.gov study NCT05690048. IPD Sharing: YES. Countries: 1. Publications: 1.
BMTP-11 in Patients With Castrate-Resistant Prostate Cancer With Bone Mets
ClinicalTrials.gov study NCT00872157. IPD Sharing: Not stated. Countries: 1. Publications: 1.
CRS & HIPEC for Platinum-Resistant Recurrent Ovarian Cancer (KOV-02R, RECOVER)
ClinicalTrials.gov study NCT05316181. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Anti-programmed Cell Death-1 Ligand 1 (aPDL-1) Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Recurrent Platinum Resistant Ovarian Cancer
ClinicalTrials.gov study NCT02659384. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Study of Pembrolizumab (MK-3475) in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)(MK-3475-199/KEYNOTE-199)
ClinicalTrials.gov study NCT02787005. IPD Sharing: YES. Countries: 0. Publications: 3.
Trial of a Behavior Change Intervention to Increase Aerobic and Resistance Exercise and Quality of Life in Older Prostate and Breast Cancer Survivors
ClinicalTrials.gov study NCT02321358. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Safety and Efficacy of BKM120 and Lapatinib in HER2+/PI3K-activated, Trastuzumab-resistant Advanced Breast Cancer
ClinicalTrials.gov study NCT01589861. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant Cancer
ClinicalTrials.gov study NCT01445379. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Clinical Study of Apatinib in the Treatment of Platinum Resistant Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT03587129. IPD Sharing: NO. Countries: 1. Publications: 15.
Study With Wee-1 Inhibitor AZD1775 (MK-1775) and Carboplatin to Treat p53 Mutated Refractory and Resistant Ovarian Cancer
ClinicalTrials.gov study NCT01164995. IPD Sharing: Not stated. Countries: 1. Publications: 2.
First-in-human Study of CCW702 in Patients With Metastatic Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT04077021. IPD Sharing: NO. Countries: 1. Publications: 2.
Identification of Biomarkers for Prediction of Response or Resistance Against Target Therapy in Gastric Cancer
ClinicalTrials.gov study NCT02305043. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Tumor-microenvironment Spatial Interaction to Identify Markers of Resistance to Therapy in HER2+ Breast Cancer Patients
ClinicalTrials.gov study NCT06518382. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Feasibility of a Remotely-Delivered Resistance Training Program for Cognitive Function in Men Living With and Beyond Prostate Cancer
ClinicalTrials.gov study NCT06828003. IPD Sharing: NO. Countries: 1. Publications: 37.
CIRCULATING MICRO-RNA (miRNA) AND AR-V7 MUTATIONAL STATUS IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (CRPC): PRIMERA+ STUDY (PROSTATE CANCER INNOVATING MARKERS OF EXPECTED RESPONSE TO AGONIST
ClinicalTrials.gov study NCT04188275. IPD Sharing: UNDECIDED. Countries: 1. Publications: 22.
TQB3616 Capsules Combined With Abiraterone Acetate Plus Prednisone in Metastatic Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT05156450. IPD Sharing: Not stated. Countries: 1. Publications: 6.
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
ClinicalTrials.gov study NCT06136650. IPD Sharing: YES. Countries: 39. Publications: 0.
Study of Oral Rucaparib With Other Anticancer Agents in Metastatic Castration Resistant Prostate Cancer Patients (RAMP)
ClinicalTrials.gov study NCT04179396. IPD Sharing: YES. Countries: 1. Publications: 0.
Active Symptom Control Alone Or In Combination With Oral Topotecan In Patients With Relapsed Resistant Small Cell Lung Cancer
ClinicalTrials.gov study NCT00276276. IPD Sharing: Not stated. Countries: 6. Publications: 1.
Bortezomib and Pegylated Liposomal Doxorubicin in BRCA Wild-type Platinum-resistant Recurrent Ovarian Cancer Patients
ClinicalTrials.gov study NCT03509246. IPD Sharing: NO. Countries: 1. Publications: 5.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.